Background: Monopharmacy with antipsychotics and antidepressants is the first-line treatment for schizophrenia and major depressive disorder (MDD) in most clinical guidelines, while polypharmacy with psychotropic agents in the treatment of schizophrenia is common in clinical practice. There are no detailed data on the prescription patterns for inpatients with mental illness with reliable diagnoses made by treating psychiatrists. Methods: We gathered prescription data at discharge from 2177 patients with schizophrenia and 1238 patients with MDD from October 2016 to March 2018. Results: The patients with schizophrenia aged between 60 and 79 were prescribed lower doses of antipsychotics and hypnotics/anxiolytics than those aged between 40 and ...
OBJECTIVE: Practice guidelines recommend the use of a combination of an antidepressant and an antips...
Objectives Previous literature on the prescription change among patients with schizophrenia mainly f...
Objective: The co-prescription of multiple antipsychotic drugs continues to increase despite a lack ...
Background: Monopharmacy with antipsychotics and antidepressants is the first-line treatment for sch...
Abstract Background Several guidelines recommend monotherapy in pharmacotherapy for schizophrenia an...
Abstract Background Polypharmacy of additional psychotropics alongside the main treatment drug (anti...
Objective: Treatment guidelines suggest distinctive medication strategies for first-episode and mult...
Objective: Although the standard of treatment for schizophrenia is antipsychotic monotherapy, overal...
Background: Though there are several recommended guidelines for treating schizophrenia, in routine c...
Background: Antipsychotic polypharmacy and prescription of high-dose antipsychotics are often used f...
[Study objectives] To investigate the proportion of inpatients with schizophrenia and major depressi...
Background: In psychiatry, polypharmacy is more the rule than the exception. The present study inves...
Background: Antipsychotic polypharmacy and prescription of high-dose antipsychotics are often used f...
ABSTRACT Objectives: The main objective of the study was prescription patterns of antipsychotics an...
Abstract Schizophrenia is a chronic mental condition presenting a wide range of symptoms. Although i...
OBJECTIVE: Practice guidelines recommend the use of a combination of an antidepressant and an antips...
Objectives Previous literature on the prescription change among patients with schizophrenia mainly f...
Objective: The co-prescription of multiple antipsychotic drugs continues to increase despite a lack ...
Background: Monopharmacy with antipsychotics and antidepressants is the first-line treatment for sch...
Abstract Background Several guidelines recommend monotherapy in pharmacotherapy for schizophrenia an...
Abstract Background Polypharmacy of additional psychotropics alongside the main treatment drug (anti...
Objective: Treatment guidelines suggest distinctive medication strategies for first-episode and mult...
Objective: Although the standard of treatment for schizophrenia is antipsychotic monotherapy, overal...
Background: Though there are several recommended guidelines for treating schizophrenia, in routine c...
Background: Antipsychotic polypharmacy and prescription of high-dose antipsychotics are often used f...
[Study objectives] To investigate the proportion of inpatients with schizophrenia and major depressi...
Background: In psychiatry, polypharmacy is more the rule than the exception. The present study inves...
Background: Antipsychotic polypharmacy and prescription of high-dose antipsychotics are often used f...
ABSTRACT Objectives: The main objective of the study was prescription patterns of antipsychotics an...
Abstract Schizophrenia is a chronic mental condition presenting a wide range of symptoms. Although i...
OBJECTIVE: Practice guidelines recommend the use of a combination of an antidepressant and an antips...
Objectives Previous literature on the prescription change among patients with schizophrenia mainly f...
Objective: The co-prescription of multiple antipsychotic drugs continues to increase despite a lack ...